eXoZymes Inc
EXOZ
7 hedge funds and large institutions have $1.62M invested in eXoZymes Inc in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.21% more ownership
Funds ownership: 0% → 1.21% (+1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$745K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$408K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$248K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$31.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10.4K |
Top Sellers
EXOZ Hedge Fund Activity: Q4 2024 in Review
7 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in eXoZymes Inc (EXOZ) for Q4 2024, worth a combined $1.62M.
Buyers outnumbered sellers: 7 funds opened new EXOZ positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $745K.
- 7 institutional investors held eXoZymes Inc (EXOZ) as of Q4 2024, up from 0 in Q3 2024.
- Funds reported $1.62M of eXoZymes Inc stock for Q4 2024.
- 7 funds opened new eXoZymes Inc positions in Q4 2024 and 0 closed out, a net change of +7 holders.
- The largest eXoZymes Inc buyer in Q4 2024 was Vanguard Group, an estimated $745K added.
Based on aggregated 13F filings for Q4 2024.